Regen Biopharma Inc's ROI from its third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Regen Biopharma Inc's ROI in the third quarter of 2026?
Due to the stockholders deficit and subsequent negative measured investments, it was not possible to calculate Regen Biopharma Inc 's return on investment (ROI) in its third quarter of 2026

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Jun 30 2026) III. Quarter	(Mar 31 2026) II. Quarter	(Dec 31 2025) I. Quarter	(Sep 30 2025) IV. Quarter	(Jun 30 2025) III. Quarter
Y / Y Investment Change TTM	-	-	-	-	-
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	-5	-5	-5	-5	-6
Return On Investment (TTM)	-	-	-	-	-
RGBP's Overall Ranking	#	#	#	#	#
Seq. Investment Change TTM	-	-	-	-	-
Seq. Net Income Change TTM	-	-	-	-	-
Net Income (TTM) in Millions	-2	-2	-2	-2	-1

RGBP Company Profile >> Back to RGBP Roi Comparisons >> See Annual RGBP Return On Investment

Return On Investment RGBP's Ranking
Within:	No.
Industry	#
Sector	#
Overall	#

Return On Investment Statistics
High	Average	Low
0 %	0 %	0 %

Financial Statements
Regen Biopharma Inc's III. Quarter Investments	$ -5 Millions	RGBP's Balance sheet
Regen Biopharma Inc's III. Quarter Income	$ -1 Millions	Quarterly RGBP's Income Statement
RGBP's Income by Division		See RGBP's Income by Division

RGBP Annual Return On Investment	(Sep 30 2025) 2025	(Sep 30 2024) 2024	(Sep 30 2023) 2023	(Sep 30 2022) 2022	(Sep 30 2021) 2021
Total Investments in Millions	-6	-5	-5	-8	-10
Y / Y Investment Growth	-	-	-	-	-
Net Income in Millions	-1	-1	1	2	-7
Y / Y Net Income Growth	-	-	-54.04 %	-	-
Annual Return On Investment	-	-	-	-	-

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
RGBP's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for RGBP's Competitors
Subscribers only: Roi for Regen Biopharma Inc's Suppliers
Subscribers only: Return On Investment for RGBP's Customers

Other Ratios
RGBP's Roa	RGBP's Inventory Turnover Ratio	RGBP's Growth Rates	RGBP's Dividend Statistics
	RGBP's Profitability Ratios	RGBP's Asset Turnover Ratio	RGBP's Dividend Growth
RGBP's Roe	RGBP's Valuation Ratios	RGBP's Financial Strength Ratios	RGBP's Dividend Payout Ratio

Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector	ROI
Interpace Biosciences Inc	100.71 %
Arbutus Biopharma Corp	99.18 %
Rigel Pharmaceuticals Inc	89.00 %
Oncotelic Therapeutics Inc	87.35 %
Actinium Pharmaceuticals Inc	84.38 %
Exelixis Inc	82.05 %
Lensar Inc	75.31 %
Ironwood Pharmaceuticals inc	70.54 %
Oramed Pharmaceuticals Inc	68.90 %
Indivior Pharmaceuticals Inc	68.79 %
Rallybio Corporation	68.28 %
Fortress Biotech Inc	68.27 %
Earth Science Tech Inc	64.38 %
Meiragtx Holdings Plc	55.83 %
Elite Pharmaceuticals Inc	53.48 %
Idexx Laboratories Inc	51.80 %
Aurinia Pharmaceuticals Inc	50.35 %
Qhslab Inc	48.94 %
Q32 Bio Inc	47.43 %
Vaxart Inc	46.17 %
Liquidia Corporation	42.09 %
Tg Therapeutics Inc	39.26 %
Medpace Holdings Inc	35.54 %
Mettler toledo International Inc	34.41 %
Eli Lilly And Company	33.95 %
Acadia Pharmaceuticals Inc	31.05 %
Caredx Inc	29.42 %
Adma Biologics Inc	28.94 %
Protalix Biotherapeutics inc	25.72 %
Pro dex Inc	24.29 %

Date modified: 2026-09-26T06:54:28+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.